Delivery Order SPE2DE24DA017-SPE2D626F2689
Award Date 10/17/25
Potential Completion Date 10/22/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Arthrex Inc. has been awarded a delivery order valued at $3,635.28 by the Defense Logistics Agency's Medical Supply Chain for an ACP MAX PRP System with ACDA functionality. The contract, issued on August 29, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 4, 2025. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $17,661.60 on May 30, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System for overseas and European use. This fixed-price contract with economic price adjustment represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, a $471 million...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,029.40 on August 27, 2025, for the ACP MAX PRP System with ACDA (autologous conditioned plasma). This fixed-price delivery order with economic price adjustment is scheduled for completion by September 2, 2025, and represents performance under Arthrex's larger indefinite delivery contract with the Defense Logistics Agency's Medical Supply Chain. The order...
- Arthrex Inc., a leading global provider of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $1,817.64 for an ACP MAX PRP System with ACDA under a Defense Logistics Agency Medical Supply Chain contract. The award, announced on August 29, 2025, is a fixed-price delivery order with economic price adjustment provisions and is set to be completed by September 4, 2025. This delivery order falls under Arthrex's larger Indefinite...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,111.90 on August 22, 2025, under a fixed-price contract with economic price adjustment provisions. The order, identified as 4569186034 and titled "ACP MAX PRP SYSTEM (W/ ACDA)," is scheduled for completion by August 27, 2025, with performance to be executed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a delivery order valued at $1,211.76 from the Defense Logistics Agency's Medical Supply Chain on June 6, 2025. The order, designated as contract 4568471533 for an ACP MAX PRP System with ACDA (Autologous Conditioned Plasma with Advanced Concentrated Data Analysis), is structured as a fixed-price delivery order with economic price adjustment provisions and carries a completion date of June...
- This is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $4,593.65 fixed-price contract with economic price adjustment is for the ACP MAX PRP SYSTEM (OUS/EU), a specialized medical device used for the extraction and concentration of platelet-rich plasma. Arthrex holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, identified as...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a delivery order valued at $6,058.80 from the Defense Logistics Agency's Medical Supply Chain on September 25, 2025, for the ACP MAX PRP System with ACDA. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 30, 2025, and will be performed in Naples, Florida. The delivery order was awarded without a set-aside designation, reflecting Arthrex's competitive...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,817.64 fixed-price delivery order to Arthrex Inc. on June 2, 2025, with a completion date of June 5, 2025. This order falls under Arthrex's existing indefinite delivery contract (IDC SPE2DE24D0020) valued at $471.0 million and running through September 1, 2029. The delivery order is for ACP MAX PRP System components with ACDA integration, which Arthrex will supply to the Naples, Florida location. The award was not set aside...